INNOMED – European Alert (9/2013)
Enrolment for the competition for funding under INNOMED programme
Entrepreneurs who are seeking sources of additional funds for projects in the scope of innovative medicine can take part in the INNOMED programme over the period from May to July. The objective of the programme is to support projects in the scope of innovative technologies of manufacturing generic medicines, searching for and development of new medicines as well as projects focused on prevention and personalisation of therapy. At this stage of programme enrolment the programme budget equals PLN 97.5 million.
* within each of the structures above there must be at least one entrepreneur that is a member of Polska Platforma Technologicznej Innowacyjnej Medycyny [Polish Platform for Technological Innovative Medicine]
|Types of projects||Projects including scientific and/or development work (Phase A) as well as activities aimed at preparation of the results of the research phase for implementation (Phase B) carried out in the area of innovative medicine|
During Phase A (research projects):
During Phase B (preparation for implementation):
Overhead costs (lump sum - up to 8% of the overall eligible costs of phase B).
Phase A (research projects):
Phase B (preparation for implementation):
The maximum amount of subsidy is PLN 10 million (phases A + B).
|When to start the
|After filing application for funding|
|Dates||10 May 2013 - 8 July 2013|
|Funding institution||Narodowe Centrum Badań i Rozwoju (NCBiR)|